Ischemic Hepatitis (Shock Liver): Evidence‑Based Definition, Diagnosis, and Management
Definition & Pathophysiology
- Ischemic hepatitis is an acute, diffuse hepatocellular injury caused by hepatic hypoperfusion that follows cardiac arrest, severe hypotension, profound heart failure, or other states of circulatory collapse, leading to massive, transient elevations of serum aminotransferases. 1
- Approximately 50 % of cases occur without documented hypotension, indicating that pre‑existing hepatic congestion (often from right‑sided heart failure) can sensitize the liver to subsequent systemic hypoperfusion. 1
Epidemiology & Prognosis
- It is the most common cause of acute liver injury in intensive‑care units, affecting roughly 2.5 %–10 % of critically ill patients. 1
- In‑hospital mortality exceeds 50 %, with deaths primarily attributable to the underlying cardiovascular or circulatory failure rather than the hepatic injury itself. 1
- Requirement for vasopressor therapy is associated with a significantly higher risk of death. 1
Clinical Presentation
- The typical patient is critically ill with underlying low‑output cardiac disease (e.g., severe congestive heart failure) or septic shock. 1
- Physical examination may reveal a smooth, tender, enlarged liver edge palpable below the costal margin, right‑upper‑quadrant discomfort, and hepatojugular reflux. 2
- Concurrent renal dysfunction and skeletal‑muscle injury are frequently observed. 1
Laboratory Findings (Diagnostic Signature)
- Serum aminotransferases rise dramatically (often > 1 000 IU/L, sometimes several thousand), with AST usually higher than ALT; bilirubin remains relatively low (< 3 mg/dL) despite the enzyme surge. 3
- An ALT/LDH ratio < 1.5 strongly favors ischemic hepatitis over viral hepatitis. 3
- Marked coagulopathy (elevated INR) disproportionate to the modest bilirubin rise improves rapidly after restoration of perfusion. 3
- Aminotransferases peak within 1–3 days and typically return toward normal within 3–11 days after hemodynamic stabilization. 3
- Lactate dehydrogenase is markedly elevated, often exceeding levels seen in viral hepatitis. 3
Imaging
| Modality | Primary Role | Typical Findings | Key Citation |
|---|---|---|---|
| Abdominal ultrasound (first‑line) | Detects diffuse hepatic hypoechogenicity, hepatomegaly, increased portal‑vein wall thickness, “starry‑sky” pattern | Same as above | 4 |
| Duplex Doppler (add‑on) | Assesses hepatic arterial and portal‑venous patency when selective hypoperfusion is suspected | Vascular flow abnormalities | 4 |
| Contrast‑enhanced CT (abdomen/pelvis) | Shows hypo‑enhancement of liver parenchyma and provides information on portal hypertension or congestion | Diffuse or segmental hypo‑enhancement | 5 |
| Contrast‑enhanced MRI | Reserved for equivocal cases; identifies non‑enhancing wedge‑shaped infarcts and evaluates perfusion | Focal perfusion defects | 5 |
- Ultrasound is mandated as the initial imaging study when ischemic hepatitis is suspected. 4
- CT and MRI are employed when ultrasound findings are inconclusive or when vascular occlusion must be excluded. 5
Differential Diagnosis (Critical Exclusions)
- Viral hepatitis: order serologies for HAV, HBV, HCV, HEV, CMV, EBV, HSV as first‑line tests. 3
- Drug‑induced liver injury: review all prescribed and over‑the‑counter agents, including herbal supplements. 1
- Budd‑Chiari syndrome: confirm with Doppler ultrasound, CT, or MR venography if hepatic vein thrombosis is suspected. 1
- Acute viral infections (including in pregnancy) and malignant infiltration must also be ruled out. 1
Management
Primary Treatment Strategy
- Definitive therapy is rapid cardiovascular support and correction of the underlying hemodynamic disturbance; no liver‑directed drug therapy is established. 1
Specific Management Steps
- Immediately restore hepatic perfusion by optimizing cardiac output, correcting hypotension, treating heart failure, and managing septic shock. 1
- Monitor for complications such as acute kidney injury, hyperammonemia, and hypoglycemia. 1
Transplantation Considerations
- Liver transplantation is rarely indicated because hepatic injury is usually reversible once circulatory stability is achieved. 1
Prognostic Monitoring
- Aminotransferases generally normalize within 7–10 days after hemodynamic stabilization. 1
- Early recognition and prompt treatment of the precipitating cardiac, circulatory, or respiratory failure are the most important determinants of survival. 1
Clinical Pitfalls (Key Alerts)
- Do not postpone cardiovascular resuscitation while awaiting liver biopsy; diagnosis is primarily clinical.
- Do not require documented hypotension to consider ischemic hepatitis—half of cases arise without recorded shock.
- Prompt vascular imaging is essential when Budd‑Chiari syndrome is a possibility, as delayed diagnosis can affect transplant eligibility. 1